MILLENNIUM MANAGEMENT LLC 13D and 13G filings for Inozyme Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-16 4:12 pm Sale | 2023-12-31 | 13G | Inozyme Pharma, Inc. INZY | MILLENNIUM MANAGEMENT LLC | 911,465 1.500% | -1,381,362 (-60.25%) | Filing |
| 2023-05-31 4:17 pm Purchase | 2023-05-22 | 13G | Inozyme Pharma, Inc. INZY | MILLENNIUM MANAGEMENT LLC | 2,292,827 5.200% | 2,292,827 (New Position) | Filing |